GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,915 | -78.1% | 665 | -71.1% | 0.00% | – |
Q2 2023 | $8,756 | -42.1% | 2,298 | -71.7% | 0.00% | – |
Q1 2023 | $15,111 | +53.4% | 8,124 | +89.7% | 0.00% | – |
Q4 2022 | $9,851 | -89.8% | 4,283 | -85.8% | 0.00% | – |
Q3 2022 | $97,000 | -69.9% | 30,241 | -48.3% | 0.00% | – |
Q2 2022 | $322,000 | +61.0% | 58,460 | -32.2% | 0.00% | – |
Q1 2022 | $200,000 | -61.7% | 86,204 | -0.2% | 0.00% | – |
Q4 2021 | $522,000 | +56.3% | 86,342 | +258.4% | 0.00% | – |
Q3 2021 | $334,000 | – | 24,092 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,153,206 | $5,864,963 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 2,360,580 | $4,390,679 | 0.73% |
Orbimed Advisors | 9,497,774 | $17,665,860 | 0.35% |
Vivo Capital, LLC | 1,463,983 | $2,723,008 | 0.19% |
Temasek Holdings (Private) Ltd | 9,901,940 | $18,417,608 | 0.11% |
EcoR1 Capital, LLC | 798,948 | $1,486,043 | 0.05% |
Brainard Capital Management LLC | 25,913 | $48,198 | 0.04% |
Schonfeld Strategic Advisors LLC | 613,179 | $1,140,512 | 0.01% |
FEDERATED HERMES, INC. | 1,298,578 | $2,415,355 | 0.01% |
Cannell Capital | 14,299 | $26,596 | 0.01% |